
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.3
22972,297 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
8,500 Listeners
1,874 Listeners
990 Listeners
2,855 Listeners
1,015 Listeners
7,711 Listeners
1,015 Listeners
3,467 Listeners
1,379 Listeners
7,841 Listeners
25,714 Listeners
5,657 Listeners
86,172 Listeners
111,073 Listeners
55,861 Listeners
53 Listeners
2,241 Listeners
2,043 Listeners
240 Listeners
23,939 Listeners
10,076 Listeners
1,286 Listeners
5,410 Listeners
1,192 Listeners
6,444 Listeners
414 Listeners
12,175 Listeners
5,969 Listeners
15,306 Listeners
59 Listeners
380 Listeners
46 Listeners
95 Listeners
4 Listeners
83 Listeners